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Abstract Psoriasis vulgaris is a chronic disease with a
multifactorial pathogenesis. It affects about 2–4 % of the
population all over the world. In course of psoriatic
arthritis, joints’ damages are observed. In patients with
psoriasis vulgaris and psoriatic arthritis, there is increased
morbidity and mortality caused by cardiovascular diseases
observed. The aim of the study is to analyze the echocar-
diography of patients with psoriasis vulgaris and psoriatic
arthritis on the basis of the literature available in PubMed
database. Abnormalities found in echocardiography of
patients with psoriasis include valvular defects (40.7 % of
the patients), left ventricle diastolic dysfunction (27.8 %),
and left ventricle hypertrophy (11.1 %). Left ventricle’s
systolic disorders, increased aorta stiffness index and
increased pulmonary artery blood pressure were also
observed in this group of patients.
Keywords Psoriasis vulgaris  Psoriatic arthritis 
Diastolic disorders  Aorta stiffness
Introduction
Psoriasis is a chronic disease with a multifactorial patho-
genesis. Its symptoms may be noticeable on the skin, they
also affect joints, and the inflammatory process manifes-
tations are observed outside the skin [3, 24, 27]. Derma-
tologists as well as cardiologists have been studying
cardiologic complications of psoriasis for many years [3,
24, 27, 44]. The reason for an increased cardiovascular
morbidity in psoriasis seems to be the chronic systemic
inflammatory process [7, 34, 35]. What is more, a number
of studies and observations confirm an increased occur-
rence of the standard atherosclerosis risk factors and/or
metabolic syndrome as well as cardiovascular diseases in
patients with psoriasis [9, 18, 22, 27, 35, 45]. Current state
of knowledge does not allow to determine if commonly
known ischemic heart disease risk factors are also psoriasis
risk factors or if they occur in course of disease and if
psoriasis alone is heart diseases risk factor. Last hypothesis
is supported by the fact that there is an increased intima-
media complex thickness of the carotid artery and
decreased nitroglycerin-induced dilatation of the brachial
artery observed in patients with psoriasis after excluding
diabetes, hypertension, renal insufficiency and cardiovas-
cular diseases in their medical history. A significantly
decreased flow-mediated vasodilatation, FMD, was
observed in patients aged 23 ± 6 years with mild and
moderate psoriasis after excluding coexistence of diseases
affecting the vascular system [42]. The psoriatic march
contains: immunological dysregulation, inflammation,
insulin resistance, endothelial dysfunction, atherosclerosis,
cardiovascular disease [7, 16, 35].
The aim of the study is to analyze the echocardiography
of patients with psoriasis vulgaris and psoriatic arthritis
referring to the available literature. The study is based on
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the analyzed publications from PubMed database using the
search terms ‘‘psoriasis’’ (Mesh) and ‘‘echocardiography’’
(Mesh). We found 27 articles in English language dated
between 1991 and 2014 and 3 articles from 1979 to 1986.
We identified 17 original studies, which we selected for
this review. First works concerning the cardiovascular
system disorders in patients with psoriasis were published
in the late 1980s. Table 1 shows the most important results
of the analyzed studies.
Epidemiologic data and pathogenesis
Psoriasis is a chronic skin disease. It is one of the most
common dermatoses and it is estimated that it occurs in
about 2–4 % of the entire population [23]. Many studies
and clinical observations show the increased standard
cardiovascular diseases’ risk factors occurrence such as
smoking, hypertension, glucose tolerance disorders and
diabetes, overweight, obesity in this group of patients [9,
18, 22, 23, 27]. An issue of psoriasis alone as a cardio-
vascular disease risk factor is being more frequently dis-
cussed nowadays. However, there are no unequivocal data
on this subject. Results of the studies show that there is an
overexpression of various pro-inflammatory cytokines,
such as interleukins (IL-1, IL-6, IL-8, IL-12, IL-15, IL-17-
20, IL-22, IL-23), TNF-a and interferon-c in psoriasis in
the skin as well as in the entire organism [30]. What is
more, cytokines’ secretion is observed to be constant [19].
These cytokines affect cellular components of the inflam-
matory infiltration within psoriatic plaque as well as the
hyperproliferation of keratinocytes. In the blood serum in
psoriasis vulgaris and psoriatic arthritis, there was a higher
level of inflammation markers, such as CRP, fibrinogen,
haptoglobin, complement fractions: C3, C4 observed [46].
There are also adipokines’ system disorders in blood, skin
and adipose tissue [14, 39], disorders in the antioxidative
system (MDA,ox-Ldl, TBA, anti-OxLDL antibodies, dis-
mutase, glutathione peroxide, catalase) observed [34]. It is
known that TNF-a as well as its receptors have a toxic
influence on the cardiomyocytes [41]. What is more, an
increased concentration of interleukin 17 occurred in
unstable coronary disease and unstable angina pectoris.
Recently, scientists have found the resemblance between
psoriasis plaques and atherosclerosis plaques structure. It
turned out that in both of them, there are activated Th1 and
Th17 cells in similar proportion. Th1 line cells are char-
acterized by an increased secretion of inflammatory
cytokines, such as TNF-a, INF-c, and IL-6, which cause
the endothelial cells dysfunction. Th17 cells produce IL-
17, which plays an important role in psoriasis pathogenesis
and initiation of the inflammatory process within various













Saricaoglu et al. [37] : nd ; : nd nd nd 12–360 nd 48
Przepiera-Be˛dzak et al. [33] nd nd nd : nd ? nd 87 nd 50.7
Gonzalez-Juanatey et al. [15] - : - - : ? nd 84 nd nd
Ardic et al. [2] - nd - - nd nd : 117.6 13.0 36.3
Gullu et al. [16] - nd - : nd nd nd 130 22.2 36.4
Karadag et al. [21] - nd - - nd nd nd nd 1.8–34 40.4
El-Mongy et al. [12] - - - - - - - 151.2 29.1 51
Shang et al. [39] (2 groups
of patients)
- nd - : nd nd nd nd nd 44.5/50.6
Biyik et al. [6] : nd nd : nd ? nd 104 1.8–60 35
Gunes et al. [17] : nd nd : : nd nd 123.2 0.4–34 nd
Bicer et al. [5] nd nd - nd nd nd : 213 12.9 37
Zhao et al. [43] - nd - - nd nd nd 188.4 15 46
Simsek et al. [40] nd nd nd : nd nd nd 129.4 0–34 35.8
Rowe et al. [36] nd nd nd : nd nd nd 132 nd 41
Pines et al. [31] nd nd nd nd nd ? nd 129.6 nd 46.5
Shang et al. [38] nd nd nd nd nd nd : 128.4 1–8 34
Osto et al. [28] - nd - - nd nd nd nd nd 37
(:), increase of parameter; (;), decrease of parameter; (?), present valvular defects; (-), no changes between groups; LVDD (mm), left
ventricular end-diastolic diameter; LVSD (mm), left ventricular end-systolic diameter; LAD (mm), left atrial diameter; nd, no data; IVRT (ms),
isovolumic relaxation time; DT (ms), deceleration time; E/A ratio, early (E) to late (A) ventricular filling velocities ratio; SPAP (mmHg), systolic
pulmonary artery pressure; ASI, aortic stiffness index; EF (%), ejection fraction
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tissues and organs [26]. An increased level of this inter-
leukin was also observed in the serum of patients with
unstable angina pectoris and in course of acute heart
infarction [20]. Circulating IL-18 is prospectively and
independently associated with CVD risk.
In about 5–20 % of patients with psoriasis, there is
damage of joints observed [37]. In this group of patients,
like in patients with psoriasis vulgaris, there is higher
occurrence of conventional cardiovascular risk factors
observed [9, 18, 22, 27]. Cardiovascular diseases are the
main cause of mortality among these patients [25, 32]. It is
estimated that risk of death in patients with psoriatic
arthritis is 1.3 times higher compared to the general pop-
ulation [33].
One of the most important diagnostic methods in heart
and vessels diseases is echocardiography, which enables to
examine morphological and physiological disorders.
Echocardiography is a method allowing to visualize
structures of the heart using reflection of ultrasounds of
1.5–10 MHz frequency. Using the Doppler method allows
to obtain important data concerning hemodynamic function
of the heart. This method is commonly available and non-
invasive. It does not require special preparation of the
patient and there are no contraindications to perform it.
However, the correct assessment of echocardiography
results requires experience.
Dimensions of the heart
Parameters assessed in echocardiography are end-diastolic
and end-systolic diameters of the left ventricle (LVDD and
LVSD, respectively) and the left atrial diameter (LAD). In
most of the analyzed studies, there were no significant
abnormalities in these dimensions of the heart observed in
patients with psoriasis vulgaris [2, 12, 15, 16, 21] and
psoriatic arthritis [39]. However, in a study conducted by
Biyik et al. [6], there were symptoms of left ventricle’s
hypertrophy observed in patients with psoriasis vulgaris.
Hypertrophy occurred more frequently in patients suffering
from psoriasis in comparison with control group (11.1 % in
group of patients with psoriasis, 4.6 % in control group).
Symptoms of the left ventricle’s hypertrophy were related
to higher blood pressure in these patients. It is worth to
notice that hypertension is a common disease occurring all
over the world and it is an etiological factor of left ven-
tricle’s hypertrophy. Gunes et al. [17] also found the
echocardiographic signs of mild left ventricle’s hypertro-
phy in 3 out of 47 patients. Saricaoglu et al. [37] assessed
heart’s dimensions in 21 patients with psoriatic arthritis
using echocardiography. They observed slight difference in
LVDD and LVSD in patients with psoriasis compared with
control group (mean LVDD was 52.76 mm in patients with
psoriasis, while it was 46.87 mm in control group). These
differences were observed in older patients, patients with a
longer course of psoriasis and psoriatic arthritis. In the
study conducted by Gonzales-Juanatey et al. [15], left
ventricle’s dimension in patients with psoriatic arthritis
was within the normal values range, but mean left atrial
diameter (LAD) was bigger compared with control group
(35.9 and 34.3 mm, respectively). Eliakim-Raz et al. [11]
observed more frequent occurrence of idiopathic car-
diomyopathy in patients with psoriasis on the basis of their
own observations and analysis of cases of patients hospi-
talized from 1980 to 2008. Based on the assessment of
2292 hospitalized patients suffering from psoriasis vulgaris
and psoriatic arthritis, it was estimated that the frequency
of idiopathic dilated cardiomyopathy in patients was
0.43 %. Potential hypotheses concerning relations between
these diseases are the genetic influence and chronic
inflammatory process with constant cytokines’ secretion
[11].
Ejection fraction
The assessment of systolic function of the left ventricle is
one of the most important aims of performing echocar-
diography. It is based on the measurement of left ventric-
ular ejection fraction (LVEF); range of the normal values is
within 55–80 %. Systolic function impairment is a base for
diagnosing congestive heart failure. In patients with pso-
riasis vulgaris and psoriatic arthritis, there were no systolic
disorders of left ventricle observed by measuring the
ejection fraction. LVEF was found to be normal in patients
with psoriasis in numerous studies [2, 11, 12, 15, 16, 21,
39]. However, Saricaoglu et al. [37] observed LVEF below
55 % in 3 out of 21 patients with psoriatic arthritis. On the
other hand, Zhao et al. [43] studies did not reveal any
significant difference in systolic function as well as dias-
tolic function of the left ventricle between patients with
severe psoriasis and control group. However, using the
speckle strain echocardiography in patients with psoriasis
they demonstrated significantly changed myocardial
deformation markers: transversal and longitudinal defor-
mation. These markers were significantly correlated with
an increased parathormone (PTH) concentration in blood.
Observed markers alterations were not correlated with
brain natriuretic peptide (BNP) concentration in blood,
which was similar in patients with psoriasis and in control
group. What is more, Bulbul Sen et al. showed significantly
higher prevalence of left ventricle systolic dyssynchrony
(assessed in tissue Doppler echocardiography) in psoriatic
patients with normal ejection fractions and normal QRS
width in ECG in comparison with the control group (34 vs.
6 %, respectively) [8]. Loss of ventricular contraction
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coordination was previously described in patients with
systolic heart failure, diabetes mellitus and myocardial
infarction. Osto et al. [28] showed a significant reduction of
coronary reserve in group of 56 young patients (mean age
of 37 years) with severe psoriasis and without any standard
cardiovascular risk factors by assessing the coronary blood
flow at rest and after adenosine infusion in transthoracal
echocardiography. According to the authors, this may
indicate on alterations in the microcirculation in the coro-
nary system, which is caused by the systemic inflammatory
process related to psoriasis only. What is more, it is the
surface of erythema, not the intensity of desquamation or
infiltration, which was correlated with extent of the coro-
nary reserve reduction.
Parameters of diastolic function
Echocardiography is also a basic method of diastolic
function of the heart assessment. In some patients, there is
an isolated diastolic heart insufficiency observed. Diastolic
dysfunction may be the first sign of heart diseases as well
as metabolic diseases. Diastolic dysfunction is more fre-
quently observed in elderly people. Assessment of diastolic
function in echocardiography is based on measuring the
mitral inflow parameters, which are isovolumic relaxation
time (IVRT), early to late ventricular filling velocities ratio
(E/A), early flow deceleration time (DT). There were no
significant diastolic function disorders in patients with
psoriasis vulgaris and psoriatic arthritis noticed on the basis
of the analyzed studies [2, 12, 15, 21]. However, many
authors notice the prevalence of occurrence of the sub-
clinical left ventricle diastolic dysfunction among patients
with psoriasis in comparison with healthy population.
There was a significantly higher frequency of the left
ventricle diastolic function disorders occurrence in com-
parison with control group (27.8 and 13.9 %, respectively)
[6]. In the same study, there was a relation between dias-
tolic dysfunction occurrence and psoriasis duration
observed—the longer psoriasis history, the more frequent
occurrence of left ventricle diastolic disorders. On the other
hand, in study conducted by Simsek et al. [40], mean
values of the analyzed parameters (DT and IVRT) were
higher in group of patients with psoriasis in comparison
with control group, but the frequency of these disorders
was comparable in both groups. Similar subclinical fea-
tures of diastolic dysfunction were observed in patients
with psoriatic arthritis using Doppler echocardiography. In
study conducted by Shang et al. [39], there were 94 patients
with psoriatic arthritis examined. Among these patients, the
researchers distinguished a group of patients without
standard cardiovascular risk factors and a group of patients
with these risk factors. In patients with standard risk
factors, occurrence of subclinical left ventricle diastolic
function disorders was found to be significantly higher
(75 % of the group). Subclinical features of left ventricle
dysfunction were found in 47.2 % of group of patients with
no risk factors in medical history. Patients presenting
echocardiographic features of left ventricle dysfunction
were older at the time of the diagnosis of psoriatic arthritis,
medical history of this disease was longer and frequency of
occurrence of hypertension and lipid metabolism disorders
was higher. However, there was no correlation of activity
and severity of disease and diastolic function disorders
noticed. It seems to be important to notice the presence of
subclinical diastolic function disorders in patients with
psoriatic arthritis with no other risk factors. Similar results
on left ventricle diastolic dysfunction in patients with
psoriatic arthritis were obtained in a study conducted by
Rowe et al. [36]. In this research, there was IVRT pro-
longation observed in 63 % of patients. This abnormality
was correlated neither with age nor with psoriasis duration.
However, in another study [15] diastolic function disorders
were found in 28 % of patients with psoriasis, but these
disorders occurred with similar frequency in control group
(24 %). Diastolic disorders were observed in 26.7 % of
cases of psoriatic arthritis [33]. In this research, diastolic
function disorders were correlated with psoriasis duration
and presence of psoriatic arthritis. Gullu et al. [16] noticed
slight abnormalities of E/A ratio, DT and IVRT among
patients with psoriasis in comparison with control group.
Saricaoglu et al. [37] also observed diastolic function
impairment demonstrated by lowered E/A ratio (\1) in 11
out of 21 patients with psoriatic arthritis.
Pulmonary artery blood pressure
Echocardiography is also used to measure blood pressure in
the pulmonary artery. Value of this parameter is obtained
by measuring maximal speed of regurgitation flow through
pulmonary valve or tricuspid valve. In a few studies on this
subject, the authors observe higher pulmonary artery blood
pressure in patients with psoriasis vulgaris and psoriatic
arthritis. Gunes et al. [17] found the presence of echocar-
diographic features of mild pulmonary hypertension in
patients with psoriasis (SPAP 30-40 mmHg). Value of
systolic blood pressure in the pulmonary artery was cor-
related with BMI, but there was no correlation between
value of pulmonary artery blood pressure and age, sex,
psoriasis duration and PASI. However, other authors did
not find any evidence of link between psoriasis and pul-
monary hypertension. In a study conducted by Gonzales-
Juanatey et al. [15], mean value of diastolic pulmonary
blood pressure in patients with psoriatic arthritis was
23.4 mmHg and it was lower when compared with control
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group (25.7 mmHg). In this study, there was no evidence
of pulmonary hypertension among patients with psoriasis
found, but in 8 % of the patients estimated diastolic pul-
monary artery blood pressure was within the highest nor-
mal values (30–35 mmHg). Pulmonary hypertension in
patients with psoriasis may be caused by the coexistence of
chronic obstructive pulmonary disease (COPD). On the
basis of the analysis of over 12 thousand patients with
psoriasis and 24-thousand-person control group (Clalit
Health Services), Dreiher et al. [10] stated that COPD is
significantly more frequent among patients with psoriasis
(OR 1.63, CI 1.47–1.81). What is more, in the logistic
regression model link between psoriasis and COPD turned
out to be significant after taking into consideration other
factors: age, sex, socioeconomic status, smoking and obe-
sity. Similar data referring to the American population
were obtained by Pearce et al. [29]. The reasons for cor-
relation between these diseases (psoriasis and COPD) are
of various origins. Both diseases are the inflammatory
states and in their course there is an increase of pro-in-
flammatory cytokines and B helper cells activity. The
autoimmunological reaction towards organs containing
elastin, such as skin and vessels, was observed in COPD
[13]. COPD may be then an autoimmunological disease
induced by smoking [1]. Both diseases may share the same
etiopathogenetic factors—smoking and more frequent in
both diseases metabolic syndrome, which contributes to
maintaining the inflammatory state by inducing antibodies
against oxidized lipoproteins [24].
Valvular defects
Valvular defects in patients with psoriasis were analyzed in
the oldest described works. In 1986, Pines et al. [31]
studied the echocardiography results in patients with pso-
riatic arthritis. They found mitral valve prolapse to be more
frequent in patients with psoriasis. Biyik et al. [6] estimated
frequency of valvular defects in patients with psoriasis to
be 40.7 %, while in control group it was 18.1 %. In another
study, 26 % of patients with psoriasis presented valvular
defects which were mitral, tricuspid and aortal insuffi-
ciency, whereas these defects were observed in 20 % of
control group [15]. Among patients with psoriatic arthritis,
aortal valve insufficiency was observed in 36.7 % of cases
and mitral insufficiency in 16.7 % of cases [33].
Aortic stiffness index
Aortic stiffness index (ASI) is an echocardiographic
parameter used to assess the elastic features of the aorta.
An abnormal, increased ASI is observed in patients with
hypertension, ischemic heart disease, heart insufficiency,
type 2 diabetes, chronic renal insufficiency. ASI is thought
to be one of the predictive factors of cardiovascular mor-
bidity and mortality. That is why this parameter is often
used during echocardiography of patients with psoriasis.
Ardic et al. [2] found ASI values to be higher in 58 patients
with psoriasis (2.7) in comparison with control group (2.0).
What is intriguing, there was a correlation between psori-
asis duration and the ASI values. There was no correlation
found between ASI value and psoriasis severity. What is
more, there was a noticeably higher concentration of the
inflammatory state marker (C-reactive protein—hs-CRP) in
serum of patients with psoriasis. There were no other sig-
nificant echocardiographic abnormalities found in this
study. Similar results were obtained by Shang et al. in 2012
[38]. The study was conducted on 73 patients with psoriatic
arthritis. Despite the lack of hypertension or left ventricle
hypertrophy features, ASI value of these patients was
higher in comparison with control group. The main factor
related to the described abnormalities was psoriasis dura-
tion. These results are consistent with the study conducted
by Bicer et al. [5], who also observed ASI value to be
higher in 27 patients with psoriasis in comparison with
control group (4.98 vs. 2.73). In this study, ASI value was
correlated with PASI and psoriasis duration. However,
Balta et al. did not find any correlation between aortic
arterial stiffness and psoriasis duration and severity [4].
Results obtained so far are not consistent for many reasons.
The authors present patients with various PASI (data in
Table 1), some of the authors do not describe PASI value,
PASI range in Shang et al. [38] study is 1.0–8.0, in Gunes
[17] studies 0.4–34, in Simsek [40] and Biyik [6] studies
1.8–60. Some of the researchers conduct studies on various
groups of patients with specific forms of psoriasis, like
pustular psoriasis or palmoplantar psoriasis and erythro-
derma affecting whole skin surface [6, 37, 38, 40]; groups
are then not homogenous. Not all the works contain the
treatment methods descriptions, some groups are treated
with methotrexate [2, 5, 15] and immunosuppressive
agents, what makes choosing and comparing groups of
patients a difficult task. However, correlation of echocar-
diography results and psoriasis demonstrated in the studies
demands paying attention to cardiovascular diseases in
patients with psoriasis and treating them adequately.
Summary
To sum up, despite a number of studies on echocardiography
results assessment in patients with psoriasis and psoriatic
arthritis, results remain incoherent and sometimes contra-
dictory. Irrefutably, there is a higher prevalence of left
ventricle diastolic dysfunction in patients with psoriasis.
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Subclinical features of left ventricle diastolic function dis-
orders are observed in 8–27 % of patients with psoriasis
vulgaris and in 28–63 % patients with psoriatic arthritis. It
seems worth noticing that diastolic function disorders are
also observed in patients with no standard cardiovascular
risk factors. In spite of generally well-preserved left ventri-
cle systolic function, the episodes of systolic disorders were
demonstrated using Speckle Tracking Echocardiography.
What is more, the aorta elasticity disorders, more frequent
occurrence of pulmonary hypertension, mitral and aortal
valves insufficiency and left ventricle hypertrophy features
with coexistence of hypertension were found in patients with
psoriasis. It seems vital to conduct further studies to pre-
cisely assess the cardiovascular system function in patients
with psoriasis as an increased cardiovascular morbidity and
mortality is observed in this group.
Although there are no clearly defined indications con-
cerning necessity of performing echocardiographic exam-
ination in patients with psoriasis, dermatologists should
pay special attention to the possibility of cardiovascular
disorders among their patients.
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